Technical Analysis for IFRX - InflaRx N.V.

Grade Last Price % Change Price Change
grade B 43.69 -3.66% -1.66
IFRX closed down 3.66 percent on Friday, March 22, 2019, on 76 percent of normal volume.

Earnings due: Apr 4

*** please verify all earnings dates ***

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Up Up Down
See historical IFRX trend table...

Date Alert Name Type % Chg
Mar 22 MACD Bearish Signal Line Cross Bearish 0.00%
Mar 22 1,2,3 Pullback Bullish Bullish Swing Setup 0.00%
Mar 22 Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
Mar 22 Wide Bands Range Expansion 0.00%
Mar 22 Down 3 Days in a Row Weakness 0.00%
Mar 21 1,2,3 Pullback Bullish Bullish Swing Setup -3.66%
Mar 21 Non-ADX 1,2,3,4 Bullish Bullish Swing Setup -3.66%
Mar 21 Wide Bands Range Expansion -3.66%
Mar 20 1,2,3 Pullback Bullish Bullish Swing Setup -5.35%
Mar 20 Non-ADX 1,2,3,4 Bullish Bullish Swing Setup -5.35%

Older signals for IFRX ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Inflarx NV, formerly Fireman BV, is a holding company for InflaRx GmbH, a Germany-based clinical-stage biopharmaceutical company. The Company's primary focus is on the development of monoclonal antibodies targeting activation products of the complement system for application in the treatment of life-threatening inflammatory diseases. Its lead product candidate, IFX-1, is an intravenously delivered first-in-class anti-C5a monoclonal antibody, undergoing Phase II clinical trial for the treatment of Hidradenitis Suppurativa (HS), a rare and chronic debilitating systemic inflammatory skin disease, and entering Phase II clinical trial for the treatment of ANCA-associated vasculitis (AAV) and other rare autoimmune diseases. The Company's product pipeline also includes IFX-2, which is in preclinical development.
Medicine Biotechnology Biopharmaceutical Medical Specialties Immunology Antibodies Immune System Monoclonal Antibodies Inflammatory Diseases
Is IFRX a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 51.3316
52 Week Low 20.31
Average Volume 127,379
200-Day Moving Average 33.187
50-Day Moving Average 37.2372
20-Day Moving Average 42.5105
10-Day Moving Average 46.886
Average True Range 2.7415
ADX 40.71
+DI 25.1811
-DI 12.4528
Chandelier Exit (Long, 3 ATRs ) 43.1071
Chandelier Exit (Short, 3 ATRs ) 39.0965
Upper Bollinger Band 52.9293
Lower Bollinger Band 32.0917
Percent B (%b) 0.56
BandWidth 49.017537
MACD Line 3.0283
MACD Signal Line 3.2453
MACD Histogram -0.217
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 46.98
Resistance 3 (R3) 47.12 46.16 46.43
Resistance 2 (R2) 46.16 45.33 46.09 46.24
Resistance 1 (R1) 44.93 44.81 44.45 44.79 46.06
Pivot Point 43.97 43.97 43.74 43.90 43.97
Support 1 (S1) 42.74 43.14 42.26 42.60 41.32
Support 2 (S2) 41.78 42.62 41.71 41.14
Support 3 (S3) 40.55 41.78 40.95
Support 4 (S4) 40.41